دوره 11، شماره 1 - ( 1-1402 )
جلد 11 شماره 1 صفحات 10-1 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nezamdoost M, Ghasemian M R, Salehiniya H, Fanoodi A, Rezapanah A, Najmadini M. Effect of Atorvastatin on clinical symptoms and laboratory markers of patients with cholecystitis: A double-blind randomized controlled trial. J Surg Trauma 2023; 11 (1) :1-10
URL: http://jsurgery.bums.ac.ir/article-1-352-fa.html
URL: http://jsurgery.bums.ac.ir/article-1-352-fa.html
Effect of Atorvastatin on clinical symptoms and laboratory markers of patients with cholecystitis: A double-blind randomized controlled trial. نشریه جراحی و تروما. 1402; 11 (1) :1-10
چکیده: (1454 مشاهده)
- Introduction: Adopting a suitable strategy to reduce the complications of cholecystectomy plays a significant role in the well-being of patients. We investigated the effects of atorvastatin on clinical symptoms, and inflammatory markers of patients undergoing cholecystectomy.
- Methods: This double-blind randomized controlled trial was conducted in Imam Reza Hospital, Birjand in 2021. In this study, 47 patients received 40 mg atorvastatin (intervention group) and 47 patients received placebo both daily for 4 weeks (placebo group). Then, the frequency of fever, abdominal pain, and nausea before and after cholecystectomy, as well as peri-operative data (duration of operation, and intraoperative bleeding) and laboratory data [White Blood Count (WBC), C-Reactive Protein (CRP), Aspartate AminoTransferase (AST), and Alkaline Phosphatase (ALT)] was collected. The data was analyzed using (SPSS Version 22) based on chi-squared, and independent t-tests at the significance level of (P≤0.05).
- Results: The duration of hospitalization was not significantly different in both groups (P=0.26), however, the duration of operation was significantly longer in the intervention group (P<0.001). The frequency of fever, abdominal pain, and nausea after cholecystectomy was not statistically different (P>0.05). The volume of intraoperative bleeding in the placebo group was more than the intervention group (P=0.05). The decrease of WBC, CRP, and the ALT levels after cholecystectomy was not statistically different (P>0.05); however, AST level after cholecystectomy was higher in the intervention group (P=0.05).
- Conclusions: The use of atorvastatin effectively reduced the volume of intraoperative bleeding. However, this intervention with this dose and duration could not have a significant role in reducing the duration of patients’ hospitalization, duration of operation, and levels of WBC, CRP, ALT, and AST.
نوع مطالعه: پژوهشي |
موضوع مقاله:
جراحی عمومی
دریافت: 1401/6/18 | پذیرش: 1401/9/21 | انتشار الکترونیک پیش از انتشار نهایی: 1401/12/5 | انتشار: 1402/2/5
دریافت: 1401/6/18 | پذیرش: 1401/9/21 | انتشار الکترونیک پیش از انتشار نهایی: 1401/12/5 | انتشار: 1402/2/5
فهرست منابع
1. Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20(6):981-996. [DOI:10.1016/j.bpg.2006.05.004] [PMID]
2. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126(5):1448-1453. [DOI:10.1053/j.gastro.2004.01.025] [PMID]
3. Bodmer M, Brauchli YB, Krähenbühl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA. 2009;302(18):2001-2007. [DOI:10.1001/jama.2009.1601] [PMID]
4. Marschall HU, Einarsson C. Gallstone disease. Journal of internal medicine. 2007;261(6):529-542. [DOI:10.1111/j.1365-2796.2007.01783.x] [PMID]
5. Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Völzke H, et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC gastroenterology. 2006;6:36. [DOI:10.1186/1471-230X-6-36] [PMID] []
6. Adachi T, Eguchi S, Muto YJJoHBPS. Pathophysiology and pathology of acute cholecystitis: A secondary publication of the Japanese version from 1992. J Hepatobiliary Pancreat Sci. 2022;29(2):212-216. [DOI:10.1002/jhbp.912] [PMID]
7. Gallaher JR, Charles AJJ. Acute Cholecystitis: A Review. 2022;327(10):965-975. [DOI:10.1001/jama.2022.2350] [PMID]
8. Strasberg SM. Cholelithiasis and acute cholecystitis. Baillieres Clin Gastroenterol. 1997;11(4):643-661. [DOI:10.1016/S0950-3528(97)90014-2] [PMID]
9. Hanabata Y, Yamanaka K, Shinkura A, Kurimoto M, Aoki H, Harada K, et al. Clinical impact of bloodstream infection on acute cholecystitis indicated for emergency cholecystectomy. J Hepatobiliary Pancreat Sci. 2022;29(3):322-328. [DOI:10.1002/jhbp.1069] [PMID]
10. Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet. 1998;351(9099):321-325. [DOI:10.1016/S0140-6736(97)08447-X] [PMID]
11. Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA. 2003;289(1):80-86. [DOI:10.1001/jama.289.1.80] [PMID]
12. Strasberg SMJJotACoS. Tokyo guidelines for the diagnosis of acute cholecystitis. 2018;227(6):624. [DOI:10.1016/j.jamcollsurg.2018.09.005] [PMID]
13. Lo CM, Liu CL, Fan ST, Lai EC, Wong J. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg. 1998;227(4):461-467. [DOI:10.1097/00000658-199804000-00001] [PMID] []
14. Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, Situ S, et al. State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications. Cardiovasc Ther. 2019;33(5):625-639. [DOI:10.1007/s10557-019-06904-x] [PMID]
15. Patel J, Abd T, Blumenthal RS, Nasir K, Superko HR. Genetics and personalized medicine--a role in statin therapy?. Curr Atheroscler Rep. 2014;16(1):384. [DOI:10.1007/s11883-013-0384-y] [PMID]
16. Squizzato A, Romualdi E, Dentali F, Ageno W. Statins for acute ischemic stroke. Cochrane Database Syst Rev. 2011(8):007551. [DOI:10.1002/14651858.CD007551.pub2]
17. Ruokoniemi P, Helin-Salmivaara A, Klaukka T, Neuvonen PJ, Huupponen R. Shift of statin use towards the elderly in 1995-2005: a nation-wide register study in Finland. Br J Clin Pharmacol. 2008;66(3):405-410. [DOI:10.1111/j.1365-2125.2008.03258.x] [PMID] []
18. Atorvastatin (Rx): Medscape; [cited 2022. Available from: https://reference.medscape.com/drug/lipitor-atorvastatin-342446.
19. Jakeways MSR, Mitchell V, Hashim IA, Chadwick SJD, Shenkin A, Green CJ, et al. Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. BJS. 2005;81(1):127-231. [DOI:10.1002/bjs.1800810146] [PMID]
20. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977-987. [DOI:10.1038/nrd1901] [PMID]
21. Pulkkinen J, Eskelinen M, Kiviniemi V, Kotilainen T, Pöyhönen M, Kilpeläinen L, et al. Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study. BMC Gastroenterology. 2014;14:119. [DOI:10.1186/1471-230X-14-119] [PMID] []
22. Biétry FA, Reich O, Schwenkglenks M, Meier CR. Statin use and risk of cholecystectomy - A case-control analysis using Swiss claims data. Expert Opin Drug Saf. 2016;15(12):1577-1582. [DOI:10.1080/14740338.2016.1240782] [PMID]
23. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39(2):157-169. [DOI:10.1016/j.gtc.2010.02.003] [PMID]
24. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80(1):38-44. [DOI:10.1093/ajcn/80.1.38] [PMID]
25. Merzon E, Weiss NS, Lustman AJ, Elhayani A, Dresner J, Vinker S. Statin administration and risk of cholecystectomy: a population-based case-control study. Expert Opin Drug Saf. 2010;9(4):539-543. [DOI:10.1517/14740338.2010.485190] [PMID]
26. Kim H-S, Lee SH, Kim H, Lee S-H, Cho JH, Lee H, et al. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea. J Clin Pharm Ther.2016;41(3):266-272. [DOI:10.1111/jcpt.12377] [PMID]
27. Kamath PS. Clinical Approach to the Patient With Abnormal Liver Test Results. Mayo Clin Proc. 1996;71(11):1089-1095. [DOI:10.4065/71.11.1089] [PMID]
28. Schirmer BD, Winters KL, Edlich RJJol-teomi. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants. 2005;15(3): 329-338. [DOI:10.1615/JLongTermEffMedImplants.v15.i3.90] [PMID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
